Request Deal Involvement

AbbVie completed the acquisition of Bretisilocin therapy of Gilgamesh Pharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Centerview Partners

financial advisors

Centerview Partners

Ropes & Gray

legal advisors

Ropes & Gray

Covington & Burling

legal advisors

Covington & Burling

or

Principals

GILGAMESH PHARMACEUTICALS (BRETISILOCIN THERAPY)

target

GILGAMESH PHARMACEUTICALS (BRETISILOCIN THERAPY)

GILGAMESH PHARMACEUTICALS

vendor

GILGAMESH PHARMACEUTICALS

ABBVIE INC

bidder

ABBVIE INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2026 Datasite

MergerLinks - Request Credit - AbbVie completed the acquisition of Bretisilocin therapy of Gilgamesh Pharmaceuticals.